Inhibition of this enzyme as an approach to sensitize cancer cells to therapies has been extensively explored12,13,97–99 and has shown to be challenging, as HO-1 is capable of protecting tumor cells from death by both inhibiting apoptosis and autophagy induced by chemotherapeutic agents42. Here, HMOX1 is linked to cancer.